Epirubicin is an anthracycline drug used for chemotherapy. It can be used in combination with other medications to treat breast cancer in patients who have had surgery to remove the tumor. It is marketed by Pfizer under the trade name Ellence in the US and Pharmorubicin or Epirubicin Ebewe elsewhere.
via PubMed
{{Drugbox | Watchedfields = changed | verifiedrevid = 461094075 | IUPAC_name = (8S,10S)-10-{[(2R,4S,5R,6S)-4-Amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione | image = Epirubicin2DACS.svg | image_class = skin-invert-image | image2 = Epirubicin ball-and-stick.png | image_class2 = bg-transparent
| tradename = Ellence | Drugs.com = | MedlinePlus = a603003 | pregnancy_category = | pregnancy_AU = D | pregnancy_US = D | legal_status = | legal_US = Rx-only | legal_UK = POM | routes_of_administration = Intravenous
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).